Wednesday, January 22, 2020
Business And Government Agencies :: essays research papers
 Business and Government Agencies           The primary focus of my topic is three fold, first if a high ranking  official from a firm were to become the Director of an agency and his former  company is asking for approval of a drug, how should the Director act in regard  to this rulemaking? The second question is not a difficult, if a former Director  were to assume a position at a firm asking for approval of a drug, how should  the former directors position influence the decisions of the agency? Finally how  could government regulation limit the potential conflicts of interest from the  "Revolving Door"?       The first scenario answer is both ethics and law based. It would be  unethical for the Director to have any influence what so ever in this  circumstance. Realistically the Director would have probably at least an  influence to the degree that those who work for him would at least try and guess  his desire for the outcome, at worst he would directly or indirectly tell them.  Probably at this point no procedural rules have been breached. This is of course  only if the director has not tried to influence the Administrative Law Judge in  which case many legal issues could be raised, more on that in question three.  Back to the ethics involved, it would be very important if the Director were to  try and be ethical about the issue he/she should give the appearance of ethical  procedure. One way this could be done is that a recommendation could be made  rulemaking be in a formal format. In addition she/he should be very careful to  limit ex parte contacts between himself and his former business associates.  Under no circumstance should the Director have conversation of any nature  involving this case. Under the circumstance that the drug was or was not  approved, the case could go before Judicial review, there any appearance of  unethical behavior could not only be be evidence to support a plaintiffs claims,  and even case a de novo review, but even worst it could be food for the media  and a public scandal.       The second question if the director were to leave and become a superior  for a firm. I don't see this as a big threat, the new director would have his  new alliances. It would seem like any influence that the former director would  have would have to be kept to a minimum in order to preserve the rulemaking  under the circumstance that the findings were on the firms behalf. As a company  representative he should not personally make ex parte contacts with the agency    					    
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.